Diabetes mellitus is associated with declines in physical function among men with and without HIV

Abstract

Objective:To determine the longitudinal relationships between abnormal glucose metabolism and physical function in persons with HIV (PWH) and without HIV.Design:Prospective cohort study of men with or at risk for HIV in four United States cities between 2006 and 2018.Methods:Men with or at risk for HIV from the Multicenter AIDS Cohort Study (MACS) had semi-annual assessments of glycemic status, grip strength, and gait speed. We used linear mixed models with random intercept to assess associations between glycemic status and physical function. Glycemic status was categorized as normal, impaired fasting glucose (IFG), controlled diabetes mellitus [hemoglobin A1C (HbA1C) <7.5%], or uncontrolled diabetes mellitus (HbA1C ≥ 7.5%).Results:Of 2240 men, 52% were PWH. Diabetes mellitus was similar among PWH (7.7%) vs. persons without HIV (6.7%, P = 0.36) at baseline. PWH had slower gait speed (1.17 vs. 1.20 m/s, P < 0.01) but similar grip strength (40.1 vs. 39.8 kg, P = 0.76) compared with persons without HIV at baseline. In multivariate models, gait speed decline was greater with controlled diabetes mellitus [−0.018 m/s (−0.032 to −0.005), P = 0.01] and grip strength decline was greater with controlled [−0.560 kg (−1.096 to −0.024), P = 0.04] and uncontrolled diabetes mellitus [−0.937 kg (−1.684 to −0.190), P = 0.01), regardless of HIV serostatus compared with normoglycemic individuals.Discussion:Abnormal glucose metabolism was associated with declines in gait speed and grip strength regardless of HIV serostatus. These data suggest that improvement in glucose control should be investigated as an intervenable target to prevent progression of physical function limitations among PWH.

Recent data on adipose tissue, insulin resistance, diabetes and dyslipidaemia in antiretroviral therapy controlled HIV-infected persons

“…In the MACS cohort, abnormal glucose metabolism was associated with declines in gait speed and grip strength, regardless of HIV serostatus. Improved glucose control is an intervenable target to prevent progression of physical function limitation and the occurrence of frailty [40].…”